Follow us on Twitter
This page is updated frequently with new Arm-related patents. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds.
Subscribe to updates on this page: Arm RSS
|| List of recent Arm-related patents
| Mobile fulfillment platform for prescription medications|
Embodiments are directed towards a method implemented by a server computer for electronic ordering of medicine by a patient from a pharmacy after a valid paper or electronic prescription has been issued by a doctor, including maintaining a database of doctors that includes records for doctors, the records including a point-of-care location where a doctor provides care to patients, receiving from a mobile device a location of the mobile device at a designated time, determining that the location of the mobile device at the designated time matches a point-of-care location for a doctor included in the database of doctors, inferring that the user of the mobile device has visited the doctor, and sending an alert message to the mobile device.. .
| Compounds and methods for the treatment of viral infections|
High throughput and virtual screening methods are disclosed that can identify potential anti-viral agents. The virtual screening methods identify agents that interact with a viral nucleoprotein binding site.
| Non-contact optical distance and tactile sensing system and method|
The systems and methods are directed to mechanical arms and manipulators, and more particularly, to optical distance sensors in use for approach, grasping and manipulation. The system may include a manipulator having an arm and a multi fingered end-effector coupled to the distal end of the arm.
| Multi-compartment step-drawer|
A multi-pocket step-drawer is disclosed that includes a dispensing drawer and a control module. The dispensing drawer has a body comprising at least one fixed wall forming at least two open-top compartments that are arranged along an axis parallel to the front-to-back axis and a ladder fixedly coupled to the body.
| Pharmacy automation optimization system and method|
A method of assessing the productivity of a pharmacy includes: (a) recording information regarding the identity and quantity of each pharmaceutical being automatically dispensed with an automated prescription monitoring unit; (b) with an overall pharmacy prescription monitoring unit, recording information regarding (i) dispensing of pharmaceuticals dispensed from the automated pharmacy machine and (ii) manual dispensing of pharmaceuticals; (c) identifying in step (a) low performing pharmaceuticals; (d) identifying in step (b) high performing pharmaceuticals dispensed manually as candidates for automated dispensing; (e) comparing low performing pharmaceuticals of step (c) with high performing pharmaceuticals of step (d) to determine whether replacement is recommended; (f) confirming whether high performing pharmaceuticals identified in step (d) are capable of automated dispensing; and (g) replacing in the automated pharmacy machine a low performing pharmaceutical identified in step (c) with a high performing pharmaceutical identified in step (d).. .
| Esophageal stent|
Stent embodiments formed of a scaffolding structure are disclosed. Some embodiments may include a valve.
| Leads with tip electrode for electrical stimulation systems and methods of making and using|
An implantable electrical stimulation lead includes a tip electrode disposed on a distal tip of the lead body. One tip electrode has a base and a separate plug attached to the base.
| Replaceable micro-surgical instrument|
The present invention provides a replaceable micro-surgical instrument which comprises a pull structure and a hollow tube attached to a grip. The hollow tube has a sleeve at one end with a u-type elastic element sliding in.
| Epilation method and apparatus thereof|
An epilation apparatus includes a body having two spaced apart holding arms, and a thread operating device which includes a powering unit supported within the body and a rotatable arm extended from the body between the holding arms. A thread is held at the epilation apparatus at a position that two free ends of the threads are held at two free ends of the holding arms and a mid-portion of the thread is held at a free end of the rotatable arm.
| Systems and methods for avoiding collisions between manipulator arms using a null-space|
Devices, systems, and methods for avoiding collisions between manipulator arms using a null-space are provided. In one aspect, the system calculates an avoidance movement using a relationship between reference geometries of the multiple manipulators to maintain separation between reference geometries.
| Manipulator arm-to-patient collision avoidance using a null-space|
Devices, systems, and methods for avoiding collisions between a manipulator arm and an outer patient surface by moving the manipulator within a null-space. In response to a determination that distance between an avoidance geometry and obstacle surface, corresponding to a manipulator-to-patient distance is less than desired, the system calculates movement of one or more joints or links of the manipulator within a null-space of the jacobian to increase this distance.
| Systems for transcatheter ablation of adventitial or perivascular tissue while preserving medial and intimal vascular integrity through convergence of energy from one or more sources, and methods of making and using same|
Under one aspect of the present invention, a system for performing renal denervation in a patient having an aorta and a renal artery and a branchpoint therebetween includes a flexible catheter comprising a main section, first and second arms, and a bifurcation between the first and second arms, the main section having a proximal end and a distal end, the distal end configured to be disposed in the aorta, the first arm being coupled to the distal end of the main section and configured to be disposed in the renal artery, the second arm being coupled to the distal end of the main section and configured to be disposed in the aorta, the bifurcation between the first and second arms being configured to engage the branchpoint between the aorta and the renal artery.. .
| Transdermal delivery system containing galantamine or salts thereof|
The present invention provides a transdermal delivery system, which comprises a drug-containing matrix layer comprising: galantamine or its pharmaceutically acceptable salt as an active ingredient; and a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive.. .
| Anti-folate antimalarials with dual-binding modes and their preparation|
The present invention is anti-folate antimalarials with dual-binding modes of the general formula (i) [refer to structure in the abstract] wherein r1 and r2 which may be the same or different are independently selected from methyl or ethyl or alkyl-phenyl, r3 is independently hydrogen, halide, lower alkyl substituted with ester, carboxylic, amide, and ether. Linker is x(ch2)ny wherein x and y which may be the same or different are independently selected from oxygen, carbon, nitrogen, substituted phenyl where n is an integer from 1 to 2-6, or pharmaceutically acceptable salts therefore.
| Method for enhancing the bioavalability of ospemifene|
Or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.. .
| Pharmaceutical composition for treating inflammation and pain|
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof..
| Pharmaceutical composition for treating inflammation and pain|
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ω-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(arylsulfonyl)alkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof..
| Ingenol-3-acylates i|
The invention relates to compounds of general formula (i) wherein r is (c1-c7)alkyl, (c2-c7)alkenyl or (c2-c7)alkynyl; wherein r is substituted with r1; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte il-8 release or responsive to induction of necrosis.. .
| Methods and compositions for preventing and treating auditory dysfunctions|
The invention provides methods for treating auditory impairments in a subject in need of treatment comprising administering to said subject an effective amount of a composition comprising, as an active agent, one or more of a carboxy alkyl ester, a quinic acid derivative, a caffeic acid derivative, a ferulic acid derivative, or a quinic acid lactone or derivative thereof or pharmaceutically acceptable salt thereof and an acceptable carrier or excipient, so as to treat auditory impairments in the subject.. .
| Novel pyrazole and imidazole derivatives useful as orexin antagonists|
The present invention relates to pyrazole and imidazole derivatives of formula (i) wherein u, v, l, x, y, r1, (r2)n and (r3)m and ring a are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (i), and especially to their use as orexin receptor antagonists.. .
| Treatment of ocular inflammatory diseases using laquinimod|
Disclosed is a method for treating an ocular inflammatory disease (oid), e.g., uveitis or conjunctivitis, comprising periodic administration of a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt thereof. Also provided is a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for use in treating a subject suffering from an oid, uveitis, bacterial conjunctivitis, viral conjunctivitis, an inflammation of the orbital tissue, the lacrimal apparatus, the eyelid, the cornea, the retina or the optic pathway.
| Remedy for psychoneurotic diseases|
A medicinal preparation for preventing and/or treating psychoneurotic diseases such as integration dysfunction and alzheimer's disease which contains tropisetron or its pharmaceutically acceptable salt as the active ingredient.. .
| Pegylated cyclopamine analogue, preparation method and uses thereof|
A pegylated cyclopamine analog, preparation method, uses thereof and methods for treating proliferative diseases using the same are disclosed. The pegylated cyclopamine analog is a compound represented by the following formula i, a compound comprising at least one group represented by the following formula i (in formula i, r is straight or branched polyethylene glycol having a molecular weight between 200 and 200,000 dalton, l and x are linking groups), or their single enantiomers, mixture of enantiomers, mixture of diastereomers, pharmaceutically acceptable salts, solvates, or hydrates..
| Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals|
The present invention is directed to the method of use of effective pharmaceutical formulations for the treatment of diseases caused by apicomplexan parasites, said formulation comprised of a salicylanilide or salicylanilide derivative, disclosed herein, alone or in combination with one or more other active or excipient pharmaceutical substances. The present invention is further directed to the method of use of effective pharmaceutical formulations for the treatment of diseases caused by apicomplexan parasites, said formulation comprised of a combination of salicylanilides or salicylanilide derivatives, disclosed herein.
| Chemokine cxcr4 receptor modulators and used related thereto|
The disclosure relates to chemokine cxcr4 receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof.
| Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors|
Thiazolylphenyl-benzenesulfonamido derivatives of formula (i) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.. .
| 1-(2-phenoxymethylheteroaryl) piperidine and piperazine compounds|
Where x, har, a, and r1 through r6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula i are serotonin and norepinephrine reuptake inhibitors.
| [1,2,4]triazolo[4,3-b][1,2,4]triazine compounds, preparation method and use thereof|
The present invention relates to a structurally novel [1,2,4]triazolo[4,3-b][1,2,4]triazine compounds represented by formula (i) or formula (ii), pharmaceutically acceptable salts thereof, prodrugs thereof, hydrates or solvates thereof, and also relates to a preparation method of the compounds, a pharmaceutical composition including a therapeutically effective amount of the compounds, as well as the use thereof as protein tyrosine kinase inhibitors, particularly as c-met inhibitors, in the preparation of medicaments for the prevention and/or treatment of diseases associated with c-met abnormality.. .
| Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents|
The invention relates to the use of glutaric acid derivatives of general formula (i), which are disclosed in the invention description, as anti-arrhythmic agents.. .
| Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors|
Corresponding enantiomeric, diastereomeric and/or tautomeric forms thereof as well as pharmaceutically acceptable salts thereof. The present compound further relates to the use of guanidine compounds as binding partners for 5-ht5 receptors for the treatment of diseases which are modulated by a 5-ht5 receptor activity, in particular for the treatment of neurodegenerative and neuropsychiatric disorders as well as the associated signs, symptoms and dysfunctions..
| Substituted pyrrolidine-2-carboxamides|
And enantiomers and pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents..
| 3-(aminoaryl)-pyridine compounds|
And pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided are pharmaceutical compositions containing these compounds and methods of treating a disease or condition mediated by cdk9 using these compounds and compositions..
| Tau imaging probe|
According to the present invention, the above problems are solved by providing a compound of a formula i (wherein a, r1, r2, r3, r4, r5, r6, ra and rb are as defined in the present description) or a pharmaceutically acceptable salt or solvate thereof.. .
| Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors|
Wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, n-oxide thereof; processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more protein tyrosine kinase mediated diseases.. .
| Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same|
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed..
| Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b|
Wherein r is selected from the group consisting of h, straight chained, branched or cyclic alkyl, co-alkyl, co-aryl, co-alkoxyalkyl, co-aryloxyalkyl, co-substituted aryl, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl, amino acid residue, mono, di, or triphosphate, or a phosphate derivative; and base is a purine or pyrimidine base which may be optionally substituted. The 2′-deoxy-β-l-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof may be administered either alone or in combination with another 2′-deoxy-β-l-erythro-pentofuranonucleoside or in combination with another anti-hepatitis b agent..
| Sustained release eye drop formulations|
This invention provides for biocompatible, biodegradable eye drop pharmaceutical formulations useful for the treatment of ocular indications. In particular, tocopherols and their esters of low water solubility, notably α-tocopheryl acetate, are exceptional vehicles for biocompatible, nonirritating topical eye drop formulations that provide sustained release of active agents..
| Aryl glycoside compound, preparation method and use thereof|
Disclosed are an aryl glycoside compound as represented by formula i or formular i′, a pharmaceutically acceptable salt thereof, optical isomer thereof or a prodrug thereof. The present invention relates to a method of preparing said aryl glycoside compound and the use thereof the aryl glycoside compound of the present invention has an excellent ability on inhibit sglt activity, especially sglt2 activity, and is diabetes-fighting medicine with great potential..
| Apparatuses and methods for exercising the arm|
In one embodiment, an exercise apparatus for exercising an arm includes a lever adapted to attach to a wheel of a wheelchair, a forearm support pivotally mounted to the lever that is adapted to support a forearm of a wheelchair user during exercise, and a resilient member attached to the lever that is adapted to resist movement of the lever by the user.. .
| Resistance training apparatus|
A resistance training apparatus includes a resistance member, and a handle assembly arranged to reciprocate between proximal and distal positions against the resistance of the resistance member. The handle assembly includes a yoke.
| Training tool for reaching out arms while catching a football and method of use thereof|
A training tool is an apparatus that teaches a user to reach their arms out from their torso in order to catch a football. The apparatus includes a waistband, a left wrist strap, a right wrist strap, a left elastic cord, and a right elastic cord.
| Putting practice aid|
The putting practice aid mounts on the front face of the putter head and provides a horizontal arm extending in the opposite direction of the intended initial trajectory of the putted golf ball and a second arm perpendicular to the intended trajectory. When these arms are maintained parallel to the putting surface it assures that the golfer has positioned the shaft at the correct angle relative to the putting surface and that the golfer has correctly aimed the club.
| Network of electronic devices assembled on a flexible support and communication method|
An embodiment of a network of electronic devices is formed on a flexible substrate by a plurality of electronic devices assembled on the flexible substrate. The electronic devices have an embedded antenna for mutual coupling of a wireless type.
| Little soothers|
“little soothers” is a plush animal that slides onto an object and plays music. It is activated (plays music) when tilted or shaken.
Popular terms: [SEARCH]
Follow us on Twitter
This listing is a sample listing of patents related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.